In a recent study from Flinders University in Australia, scientists found a link between beta-blockers and survival outcomes in some breast cancer patients.
Beta-blockers, commonly used to manage high blood pressure, were linked to worse survival outcomes in patients with HER2 (Human Epidermal Growth Factor Receptor 2) positive advanced breast cancer.
In the study, researchers used data from 2,777 patients. They found worse survival outcomes for patients with HER2 positive advanced breast cancer who used beta-blocker drugs.
The findings highlight a group of breast cancer patients whose survival outcomes are profoundly poorer.
About 20% of breast cancer patients overexpress HER2, and cardiovascular toxicities are a known complication of anti-HER2 therapies.
This study importantly shows a subgroup of patients in which the team recommends further tests to find strategies to improve treatment outcomes.
The researchers say that future research should aim to gain a deeper understanding of the effects of beta-blockers on specific breast cancer subtypes, cancer types, and cancer treatments.
If you care about cancer risk, please read studies about supplements and cancer, and this inexpensive drug could help treat cancer.
For more information about cancer risk, please see recent studies about common vegetable that may help lower your cancer risk, and results showing drinking sugary juice every day may increase your cancer risk.
The study was published in the Frontiers in Oncology and conducted by Michael Sorich et al.
Copyright © 2022 Knowridge Science Report. All rights reserved.
